MoneyWorks4Me

Jubilant Life Sciences’ arm redeems $100 million notes

22 Nov 2019 Evaluate

Jubilant Life Sciences’ wholly-owned subsidiary -- Jubilant Pharma has redeemed the principal amount of $100 million on pro-rata basis out of $300 million notes at a redemption price of 102.43750% together with the accrued interest till date.

Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..